Cummings School of Veterinary Medicine at Tufts University
Kristine E Burgess

Oncology

Dr. Kristine Burgess is a veterinary oncologist at the Foster Hospital for Small Animals, Dr.who also teaches medical oncology at the Cummings School of Veterinary Medicine. She collaborates with several other institutions to run clinical trials for new and advanced cancer treatments for dogs and cats, which may lead to better oncology options for both pets and humans. She is board certified in oncology from the American College of Veterinary Internal Medicine.

Growing up near Boston, Dr. Burgess had many pets and early on considered a career in veterinary medicine. However, after earning a bachelor's degree from the University of Massachusetts, she considered a career in basic science cancer research. She eventually completed research at the world-renowned Dana-Farber Cancer Institute and the Netherlands Cancer Institute, where her cancer medicine and research interests were honed. She ultimately returned to her first love and went on to earn her DVM from the Cummings School then joined its faculty after completing her residency training at the University of Wisconsin.

While at the Cummings School she has had the good fortune of working directly with fourth-year students and residents during their clinical rotations within the Foster Hospital for Small Animals. Dr. Burgess is honored and thrilled to have the opportunity to shape the future of veterinary students and residents in their careers as veterinarians and veterinary specialists. As she says, I love the diverse mix of teaching, research and clinical service that comprise my position at Tufts University.

One of the most satisfying aspects of my specialty is the ability to do clinical trials using new or novel chemotherapy or immunotherapy, she says. Much like human medicine, these clinical trials can be an excellent option for pets with advanced cancers or for owners with financial limitations. It has been our experience that certain pets with a poor or grave prognosis can benefit from these treatments. It is those patients who have benefited most from these trials that provide a great deal of satisfaction, and the two-way path between veterinary and human oncology can benefit both animals and humans. There is no better feeling than knowing you made a difference in the life of an animal and the family who brought that animal to us. I am grateful for being able to offer our cancer patients top-notch, state-of-the-art and compassionate care.

Dr. Burgess lives with her husband and daughter, three dogs and many cats. She enjoys live music, biking, hiking and traveling.

Education

  • DVM - Tufts University - 1997
  • Harvard University Masters of Liberal Arts Extension Studies, Concentration in Science – 1991
  • BS - University of Massachusetts - 1988

Board Certification

  • American College of Veterinary Internal Medicine - Oncology

Cutaneous lymphoma of the tarsus in cats: 23 cases (2000-2012)

Author(s):Burr, H.D. | Keating, J.H. | Clifford, C.A. | Burgess, K.E.
Publication year: 2014
Journal / Book title: Journal of the American Veterinary Medical Association

Mast cell tumor invading the cornea in a horse

Author(s):Halse, S. | Pizzirani, S. | Parry, N.M.A. | Burgess, K.E.
Publication year: 2014
Journal / Book title: Veterinary Ophthalmology

Histologic and immunohistochemical characterization of thymic epithelial tumours in the dog

Author(s):Burgess, K.E. | Deregis, C.J. | Brown, F.S. | Keating, J.H.
Publication year: 2013
Journal / Book title: Veterinary and Comparative Oncology

Molecular profiling reveals prognostically significant subtypes of canine lymphoma

Author(s):Frantz, A.M. | Sarver, A.L. | Ito, D. | Phang, T.L. | Karimpour-Fard, A. | Scott, M.C. | Valli, V.E.O. | Lindblad-Toh, K. | Burgess, K.E. | Husbands, B.D. | Henson, M.S. | Borgatti, A. | Kisseberth, W.C. | Hunter, L.E. | Breen, M. | O'Brien, T.D. | Modiano, J.F.
Publication year: 2013
Journal / Book title: Veterinary Pathology

Doxorubicin and deracoxib adjuvant therapy for canine splenic hemangiosarcoma: A pilot study

Author(s):Kahn, S.A. | Mullin, C.M. | De Lorimier, L.-P. | Burgess, K.E. | Risbon, R.E. | Fred III, R.M. | Drobatz, K. | Clifford, C.A.
Publication year: 2013
Journal / Book title: Canadian Veterinary Journal

An Update on Ferret Lymphoma: A Proposal for a Standardized Classification of Ferret Lymphoma

Author(s):Mayer, J. | Burgess, K.
Publication year: 2012
Journal / Book title: Journal of Exotic Pet Medicine

Imaging characteristics of intrathoracic histiocytic sarcoma in dogs

Author(s):Tsai, S. | Sutherland-Smith, J. | Burgess, K. | Ruthazer, R. | Sato, A.
Publication year: 2012
Journal / Book title: Veterinary Radiology and Ultrasound

Angiofibroma of the nasal cavity in 13 dogs

Author(s):Burgess, K.E. | Green, E.M. | Wood, R.D. | Dubielzig, R.R.
Publication year: 2011
Journal / Book title: Veterinary and Comparative Oncology

A tumor-related lymphoid progenitor population supports hierarchical tumor organization in canine B-cell lymphoma

Author(s):Ito, D. | EndicottM.M. | Jubala, C.M. | Helm, K.M. | Burnett, R.C. | Husbands, B.D. | Borgatti, A. | Henson, M.S. | Burgess, K.E. | Bell, J.S. | Kisseberth, W.C. | Valli, V.E. | Cutter, G.R. | Avery, A.C. | Hahn, K.A. | O'Brien, T.D. | Modiano, J.F.
Publication year: 2011
Journal / Book title: Journal of Veterinary Internal Medicine

Refining tumor-associated aneuploidy through 'genomic recoding' of recurrent DNA copy number aberrations in 150 canine non-Hodgkin lymphomas

Author(s):Thomas, R. | Seiser, E.L. | Motsinger-Reif, A. | Borst, L. | Valli, V.E. | Kelley, K. | Suter, S.E. | Argyle, D. | Burgess, K. | Bell, J. | Lindblad-Toh, K. | Modiano, J.F. | Breen, M.
Publication year: 2011
Journal / Book title: Leukemia and Lymphoma

Efficacy of Maropitant in the Prevention of Delayed Vomiting Associated with Administration of Doxorubicin to Dogs

Author(s):Rau, S.E. | Barber, L.G. | Burgess, K.E.
Publication year: 2010
Journal / Book title: Journal of Veterinary Internal Medicine

Identifying and treating anal sac adenocarcinoma in dogs

Author(s):Gauthier, M. | Barber, L.G. | Burgess, K.E.
Publication year: 2009
Journal / Book title: Veterinary Medicine

Response of canine cutaneous epitheliotropic lymphoma to lomustine (CCNU): A retrospective study of 46 cases (1999-2004)

Author(s):Risbon, R.E. | De Lorimier, L.P. | Skorupski, K. | Burgess, K.E. | Bergman, P.J. | Carreras, J. | Hahn, K. | LeBlanc, A. | Turek, M. | Impellizeri, J. | Fred III, R. | Wojcieszyn, J.W. | Drobatz, K. | Clifford, C.A.
Publication year: 2006
Journal / Book title: Journal of Veterinary Internal Medicine

Toxicity, dosage, and efficacy of vinorelbine (navelbine) in dogs with spontaneous neoplasia

Author(s):Poirier, V.J. | Burgess, K.E. | Adams, W.M. | Vail, D.M.
Publication year: 2004
Journal / Book title: Journal of Veterinary Internal Medicine

Efficacy and toxicity of paclitaxel (Taxol) for the treatment of canine malignant tumors

Author(s):Poirier, V.J. | Hershey, A.E. | Burgess, K.E. | Phillips, B. | Turek, M.M. | Forrest, L.J. | Beaver, L. | Vail, D.M.
Publication year: 2004
Journal / Book title: Journal of Veterinary Internal Medicine

Treatment of immune-mediated hemolytic anemia in dogs with cyclophosphamide.

Author(s):Burgess, K. | Moore, A. | Rand, W. | Cotter, S.M.
Publication year: 2000
Journal / Book title: Journal of veterinary internal medicine / American College of Veterinary Internal Medicine

General Research Interests

  • Understanding the molecular mechanisms that trigger the development of canine/feline cancer and applying those findings into improved diagnostic capabilities and therapeutic options for treatment
  • Participating in clinical trials that evaluate the use of novel chemotherapeutics and immunotherapies in various malignancies

Research Interests by Area

Spontaneous Animal Disease Models
  • Lymphoma, osteosarcoma, transitional cell carcinoma, prostatic cancer, hemangiosarcoma, mammary (breast) cancer, squamous cell carcinoma in cats

Research Interests by Organ System and Disease

Oncology and Cancer Research and Clinical Trials
  • Genetic mapping of canine B cell lymphoma. Clinical oncology, spontaneous animal disease models of cancer, clinical trials